Novel adaptive and innate immunity targets in hypertension
NICE guidance (TA875 for semaglutide, TA664 for liraglutide) specifies that treatment should be discontinued if certain weight loss thresholds are not met at specified timepoints
Uittenbogaard et al., 2000)
To examine the potential for LCLT supplementation to impact recovery from exercise, we measured indicators of adenine nucleotide degradation (hypoxanthine and uric acid), free radical formation (MDA and xanthine oxidase), cell membrane damage (creatine kinase, FABP, and myoglobin), muscle disruption/damage, and perceived muscle soreness
Health coaching is currently paused
I think the best way to think through data like this is to consider what possibilities could be true